pharmacovigilance

R&D

A practical route through regulatory uncertainty in clinical...

Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.

News

Parexel buys Vitrana to boost patient safety toolkit

Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

Market Access

The Windsor Framework: Insights on the regulatory shift for ...

The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the pharmaceutical sector

Market Access

Keeping local affiliates on track with pharmacovigilance

Local affiliates can be overwhelmed by the often-competing demands of global companies and local health authorities.

Digital

Transforming pharmacovigilance: The revolutionary impact of ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in pharmacovigilance, the science dedicated to ensuring drug safety.